Q9984 HCPCS Level II code: Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
CMS terminated Q9984: its last date of service was Dec 31, 2017. It stays here for looking up older claims; newer services need a current code.
Official description
Q9984Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
Short description: Kyleena, 19.5 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with Q9984 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Non-covered by Medicare statute
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Other medical items or services
- BETOS category
- Minor procedures - other (Medicare fee schedule)
- Coverage statute
- 1862(a)(1)
- Cross-reference
- See J7296
- Added
- Jul 1, 2017
- Terminated after
- Dec 31, 2017
Where Q9984 sits
- 1Q codesTemporary codes
- 2Terminated Q9984Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code Q9984 still valid?
No. CMS terminated Q9984; its last date of service was Dec 31, 2017. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover Q9984?
CMS lists Q9984’s Medicare coverage as “Non-covered by Medicare statute” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q9984
All Q codesQ9978Netupitant 300 mg and palonosetron 0.5 mgQ9979Injection, alemtuzumab, 1 mgQ9980Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mgQ9981Rolapitant, oral, 1 mgQ9982Flutemetamol f18, diagnostic, per study dose, up to 5 millicuriesQ9983Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuriesQ9985Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mgQ9986Injection, hydroxyprogesterone caproate, (makena), 10 mgQ9987Pathogen(s) test for plateletsQ9988Platelets, pheresis, pathogen-reduced, each unitQ9989Ustekinumab, for intravenous injection, 1 mgQ9991Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg